Bovine Leukemia Inhibitory Factor (LIF) Polyclonal Antibody

• Background:

  Leukemia inhibitory factor, or LIF, is a member of the IL-6 family. LIF affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. Leukemia inhibitory factor derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to LIF include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation. p53 regulated LIF has been shown to facilitate implantation in the mouse model and possibly in humans. Removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential or pluripotency. LIF is typically added to stem cell culture medium to reduce spontaneous differentiation.

• Description:

  The Bovine Leukemia Inhibitory Factor (LIF) polyclonal antibody is unlabeled and has been qualified for use in ELISA and Western blot applications. It is the capture antibody in the Kingfisher Biotech Bovine Leukemia Inhibitory Factor ELISA. The Bovine Leukemia Inhibitory Factor antibody was produced in chickens and is antigen-affinity purified. The reactivity by species is: (Bovine LIF - Strong) (Canine LIF - Weak) (Rabbit LIF - Moderate) (Swine LIF - Weak) . For research use only.

• Host:

  Rabbit

• Label:

  Unconjugated

• Applications:

  ELISA, ELISpot, Flow Cytometry, Neutralization, Western Blot

• Purification:

  Antigen-affinity

• Homology:

  Bos taurus (cattle)

• Storage Temperature:

  2°C to 8°C

• Scientific Category:

  Antibody